Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Capital Employed: 2021-2024

Historic Return on Capital Employed for Journey Medical (DERM) over the last 4 years, with Dec 2024 value amounting to -0.32%.

  • Journey Medical's Return on Capital Employed rose 45.00% to -0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.13%, marking a year-over-year increase of 45.00%. This contributed to the annual value of -0.32% for FY2024, which is 27.00% down from last year.
  • Per Journey Medical's latest filing, its Return on Capital Employed stood at -0.32% for FY2024, which was down 647.49% from -0.04% recorded in FY2023.
  • Journey Medical's 5-year Return on Capital Employed high stood at -0.04% for FY2023, and its period low was -1.52% during FY2021.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.32% (2024), whereas its average is -0.39%.
  • As far as peak fluctuations go, Journey Medical's Return on Capital Employed spiked by 76bps in 2023, and later decreased by 27bps in 2024.
  • Over the past 4 years, Journey Medical's Return on Capital Employed (Yearly) stood at -1.52% in 2021, then skyrocketed by 72bps to -0.80% in 2022, then spiked by 76bps to -0.04% in 2023, then declined by 27bps to -0.32% in 2024.